NCT05561088 Efficacy and Safety of Head Acupuncture After Mechanical Thrombectomy for Acute Ischemic Stroke
| NCT ID | NCT05561088 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xi'an No.3 Hospital |
| Condition | Acupuncture |
| Study Type | INTERVENTIONAL |
| Enrollment | 272 participants |
| Start Date | 2023-04-27 |
| Primary Completion | 2026-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 272 participants in total. It began in 2023-04-27 with a primary completion date of 2026-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate the efficacy and safety of head acupuncture combined with endovascular therapy for cerebral infarction compared with endovascular therapy alone
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years; * Patients with acute ischemic stroke who received endovascular treatment within 24 hours of onset; * 6 \< NIHSS ≤25; * ASPECT score ≥6 points; * Signed Informed consent. Exclusion Criteria: * CT or brain MRI confirmed intracranial tumor and intracranial hemorrhage; * Contraindications of contrast media; * Dementia or mental illness，unable to cooperate with treatment and follow-up; * The expected survival time was less than 3 months; * Women who are pregnant, planning to become pregnant or breastfeeding; * Currently participating in other clinical trials.
Frequently Asked Questions
Who can join the NCT05561088 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Acupuncture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05561088 currently recruiting?
Yes, NCT05561088 is actively recruiting participants. Visit ClinicalTrials.gov or contact Xi'an No.3 Hospital to inquire about joining.
Where is the NCT05561088 trial being conducted?
This trial is being conducted at Xi'an, China.
Who is sponsoring the NCT05561088 clinical trial?
NCT05561088 is sponsored by Xi'an No.3 Hospital. The trial plans to enroll 272 participants.